Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

Acta Neuropathologica Communications
Leeanne McGurkNancy M Bonini

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating and fatal motor neuron disease. Diagnosis typically occurs in the fifth decade of life and the disease progresses rapidly leading to death within ~ 2-5 years of symptomatic onset. There is no cure, and the few available treatments offer only a modest extension in patient survival. A protein central to ALS is the nuclear RNA/DNA-binding protein, TDP-43. In > 95% of ALS patients, TDP-43 is cleared from the nucleus and forms phosphorylated protein aggregates in the cytoplasm of affected neurons and glia. We recently defined that poly(ADP-ribose) (PAR) activity regulates TDP-43-associated toxicity. PAR is a posttranslational modification that is attached to target proteins by PAR polymerases (PARPs). PARP-1 and PARP-2 are the major enzymes that are active in the nucleus. Here, we uncovered that the motor neurons of the ALS spinal cord were associated with elevated nuclear PAR, suggesting elevated PARP activity. Veliparib, a small-molecule inhibitor of nuclear PARP-1/2, mitigated the formation of cytoplasmic TDP-43 aggregates in mammalian cells. In primary spinal-cord cultures from rat, Veliparib also inhibited TDP-43-associated neuronal death. These studies uncover that PAR activ...Continue Reading

References

Aug 1, 1991·Annals of Neurology·J D RothsteinD B Drachman
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·P J ShawH J Wastell
Dec 24, 1996·Biochemical and Biophysical Research Communications·G M ShahG G Poirier
Dec 9, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·K TakahashiJ Zhang
Dec 9, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M EndresM A Moskowitz
Jun 2, 2001·The New England Journal of Medicine·L P Rowland, N A Shneider
Jan 17, 2003·Journal of Neuropathology and Experimental Neurology·Seung H KimStanley H Appel
Dec 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shuji HanaiMasanao Miwa
Jan 8, 2004·Journal of the National Cancer Institute·Christopher R CalabreseNicola J Curtin
Sep 21, 2004·Journal of Bioenergetics and Biomembranes·Valina L Dawson, Ted M Dawson
Oct 30, 2004·Stroke; a Journal of Cerebral Circulation·Eun-Mi ParkCostantino Iadecola
May 25, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alberto Chiarugi
Jul 28, 2005·The European Journal of Neuroscience·Seong-Ho KohSeung Hyun Kim
Nov 4, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carsten CulmseeNikolaus Plesnila
Jun 30, 2006·Biochimica Et Biophysica Acta·L Van Den BoschW Robberecht
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Valérie SchreiberGilbert de Murcia
Sep 8, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jelena Mojsilovic-PetrovicRobert G Kalb
Mar 16, 2007·Journal of Neuropathology and Experimental Neurology·Manuela NeumannVirginia M-Y Lee
Feb 23, 2008·Trends in Biochemical Sciences·Paul Anderson, Nancy Kedersha
Mar 1, 2008·Science·Jemeen SreedharanChristopher E Shaw
Jun 4, 2008·Journal of Neuropathology and Experimental Neurology·Kunihiro UryuManuela Neumann
Jun 12, 2008·Annals of Neurology·Masato HasegawaHaruhiko Akiyama
Feb 11, 2009·Archives of Neurology·Felix GeserJohn Q Trojanowski
Jun 26, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jelena Mojsilovic-PetrovicRobert G Kalb

❮ Previous
Next ❯

Citations

Apr 18, 2019·Open Biology·Luca PalazzoIvan Ahel
Feb 12, 2020·Medicinal Research Reviews·Heike J WobstJames Shorter
May 5, 2020·Emerging Topics in Life Sciences·Richard John Wheeler
Oct 28, 2019·Nature Communications·Hermann Broder SchmidtRajat Rohatgi
May 30, 2020·British Journal of Pharmacology·Emanuele Buratti
Sep 24, 2020·Expert Opinion on Therapeutic Targets·Andreia Neves-CarvalhoPatrícia Maciel
Aug 28, 2020·British Journal of Pharmacology·Wei WangQiaojun He
Aug 21, 2019·Annual Review of Genetics·Simon Alberti, Dorothee Dormann
Sep 5, 2020·Nature Reviews. Drug Discovery·Nicola J Curtin, Csaba Szabo
May 16, 2020·Journal of Cell Science·Leeanne McGurkNancy M Bonini
Dec 19, 2018·Nature Neuroscience·Edward M Barbieri, James Shorter
Apr 18, 2020·Trends in Cell Biology·Anthony K L Leung
Mar 27, 2021·Molecular Biology Reports·Vijay Kumar ArruriShashi Bala Singh
Apr 1, 2021·Molecular Neurobiology·Laura N PuentesRobert H Mach
Apr 4, 2021·International Journal of Molecular Sciences·Wanil KimKyung-Ha Lee
Oct 14, 2020·Developmental Cell·Aurélie ZbindenMagdalini Polymenidou
May 11, 2021·Frontiers in Cellular Neuroscience·Daniel A SolomonSarah Mizielinska
Jun 4, 2021·Neurochemistry International·Joshua M MarcusShaida A Andrabi
Jun 12, 2021·DNA Repair·Tanya T Paull
Aug 7, 2021·Biomolecules·Macy L Sprunger, Meredith E Jackrel
Aug 16, 2021·Pharmacology & Therapeutics·Zsofia Lengyel-ZhandRobert H Mach

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transgenic

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.